Article
Telomerase: a good target in hepatocellular carcinoma? An overview of relevant preclinical data
2 Sept 2022
Abstract excerpt
INTRODUCTION: The expression of telomerase reverse transcriptase (TERT) in liver is restricted to rare cells, that are able to replace senescent hepatocytes and regenerate tissue in response to hepatic damage, while becoming extinguished in differentiated progeny cells. TERT gene is permanently activated in liver neoplasms from the very early stage of the hepatocarcinogenesis mainly through the accumulation of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
